<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1206" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1206/" /><meta name="ncbi_pagename" content="Fukuyama Congenital Muscular Dystrophy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Fukuyama Congenital Muscular Dystrophy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Fukuyama Congenital Muscular Dystrophy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/07/03" /><meta name="citation_author" content="Kayoko Saito" /><meta name="citation_pmid" content="20301385" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1206/" /><meta name="citation_keywords" content="FCMD" /><meta name="citation_keywords" content="Fukuyama Type Congenital Muscular Dystrophy" /><meta name="citation_keywords" content="FCMD" /><meta name="citation_keywords" content="Fukutin" /><meta name="citation_keywords" content="FKTN" /><meta name="citation_keywords" content="Fukuyama Congenital Muscular Dystrophy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Fukuyama Congenital Muscular Dystrophy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Kayoko Saito" /><meta name="DC.Date" content="2019/07/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1206/" /><meta name="description" content="Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that result in changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia. Mild, typical, and severe phenotypes are recognized. Onset typically occurs in early infancy with poor suck, weak cry, and floppiness. Affected individuals have contractures of the hips, knees, and interphalangeal joints. Later features include myopathic facial appearance, pseudohypertrophy of the calves and forearms, motor and speech delays, intellectual disability, seizures, ophthalmologic abnormalities including visual impairment and retinal dysplasia, and progressive cardiac involvement after age ten years. Swallowing disturbance occurs in individuals with severe FCMD and in individuals older than age ten years, leading to recurrent aspiration pneumonia and death." /><meta name="og:title" content="Fukuyama Congenital Muscular Dystrophy" /><meta name="og:type" content="book" /><meta name="og:description" content="Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that result in changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia. Mild, typical, and severe phenotypes are recognized. Onset typically occurs in early infancy with poor suck, weak cry, and floppiness. Affected individuals have contractures of the hips, knees, and interphalangeal joints. Later features include myopathic facial appearance, pseudohypertrophy of the calves and forearms, motor and speech delays, intellectual disability, seizures, ophthalmologic abnormalities including visual impairment and retinal dysplasia, and progressive cardiac involvement after age ten years. Swallowing disturbance occurs in individuals with severe FCMD and in individuals older than age ten years, leading to recurrent aspiration pneumonia and death." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1206/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/fcmd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1206/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88A54EE04058810000000004BC01A8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1206_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1206_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fryns/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fum/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1206_"><span class="title" itemprop="name">Fukuyama Congenital Muscular Dystrophy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: FCMD</div><p class="contrib-group"><span itemprop="author">Kayoko Saito</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1206_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1206_ai__"><div class="contrib half_rhythm"><span itemprop="author">Kayoko Saito</span>, MD, PhD<div class="affiliation small">Professor of Special Appointment, Institute of Medical Genetics<br />Tokyo Women's Medical University School of Medicine<br />Tokyo, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.umwt@okoyak.otias" class="oemail">pj.ca.umwt@okoyak.otias</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 26, 2006</span>; Last Update: <span itemprop="dateModified">July 3, 2019</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="fcmd.Summary" itemprop="description"><h2 id="_fcmd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that result in changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia. Mild, typical, and severe phenotypes are recognized. Onset typically occurs in early infancy with poor suck, weak cry, and floppiness. Affected individuals have contractures of the hips, knees, and interphalangeal joints. Later features include myopathic facial appearance, pseudohypertrophy of the calves and forearms, motor and speech delays, intellectual disability, seizures, ophthalmologic abnormalities including visual impairment and retinal dysplasia, and progressive cardiac involvement after age ten years. Swallowing disturbance occurs in individuals with severe FCMD and in individuals older than age ten years, leading to recurrent aspiration pneumonia and death.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of FCMD is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FKTN</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physical therapy and stretching exercises, treatment of orthopedic complications, assistance devices such as long leg braces and wheelchairs, use of noninvasive respiratory aids or tracheostomy, prompt treatment of acute respiratory tract infections, antiepileptic drugs, medical and/or surgical treatment for gastroesophageal reflux, gastrostomy tube placement when indicated to assure adequate caloric intake, cardiomyopathy treatment as per cardiologist.</p><p><i>Surveillance:</i> Monitor:</p><ul><li class="half_rhythm"><div>Respiratory function in individuals with advanced disease;</div></li><li class="half_rhythm"><div>For myocardial involvement by chest x-ray, ECG, and echocardiography in individuals older than age ten years;</div></li><li class="half_rhythm"><div>Gastrointestinal function, and for signs/symptoms of gastroesophageal reflux;</div></li><li class="half_rhythm"><div>For foot deformities and scoliosis.</div></li></ul></div><div><h4 class="inline">Genetic counseling.</h4><p>FCMD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="fcmd.Diagnosis"><h2 id="_fcmd_Diagnosis_">Diagnosis</h2><div id="fcmd.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy <b>should be suspected</b> in individuals with the following clinical, imaging, laboratory, and histopathology findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Early-infantile onset of hypotonia and weakness with contractures of the hips, knees, and interphalangeal joints (in 100% of individuals)</div></li><li class="half_rhythm"><div>Severe motor and speech delays and intellectual disability with relative preservation of social skills (100%)</div></li><li class="half_rhythm"><div>Static course until early childhood, followed by diffuse and extensive muscle wasting (most prominent proximally) and later progressive joint contractures (100%)</div></li><li class="half_rhythm"><div>Myopathic facial appearance (100%)</div></li><li class="half_rhythm"><div>Pseudohypertrophy of the calves and forearms in late infancy (50%)</div></li><li class="half_rhythm"><div>Seizures (febrile and/or afebrile) (50%)</div></li><li class="half_rhythm"><div>Ophthalmologic abnormalities, including visual impairment in 53% and retinal abnormalities in 32% [<a class="bk_pop" href="#fcmd.REF.saito.2001">Saito &#x00026; Kobayashi 2001</a>]. Retinal abnormality when present is mild and focal. Retinal dysplasia, a pathologic diagnosis, is based on the finding of rosettes of immature photoreceptors.</div></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul><p><b>Neuroimaging findings.</b> MRI reveals the findings of cobblestone lissencephaly comprising five major abnormalities including the following:</p><ul><li class="half_rhythm"><div>Irregular or pebbled brain surface; broad gyri with a thick cortex (pachygyria) in the frontal, parietal, and temporal regions; and sometimes areas of small and irregular gyri that resemble polymicrogyria</div></li><li class="half_rhythm"><div>Dilated lateral ventricles</div></li><li class="half_rhythm"><div>White matter abnormality with hyperintensity on T<sub>2</sub>-weighted images and hypointensity on T<sub>1</sub>-weighted images [<a class="bk_pop" href="#fcmd.REF.kato.2000.385">Kato et al 2000</a>] indicative of delayed myelination [<a class="bk_pop" href="#fcmd.REF.kato.2006.261">Kato et al 2006</a>, <a class="bk_pop" href="#fcmd.REF.kato.2010.s127">Kato et al 2010</a>] rather than dysmyelination</div></li><li class="half_rhythm"><div>Mild brain stem hypoplasia in some individuals</div></li><li class="half_rhythm"><div>Cerebellar polymicrogyria and cerebellar cysts (23/25 individuals [<a class="bk_pop" href="#fcmd.REF.aida.1994.1755">Aida et al 1994</a>])</div></li></ul><p>In addition:</p><ul><li class="half_rhythm"><div>The cortex is typically no more than approximately 1 cm in thickness.</div></li><li class="half_rhythm"><div>The opercula are poorly developed, leaving an open Sylvian fissure.</div></li></ul><p><b>Laboratory findings.</b> Serum creatine kinase (CK) concentration:</p><ul><li class="half_rhythm"><div>Age &#x0003c;6 years: 10-60x above normal</div></li><li class="half_rhythm"><div>Age &#x02265;7 years: 5-20x above normal</div></li><li class="half_rhythm"><div>Bedridden individuals: normal</div></li></ul><p><b>Histopathology.</b> Muscle biopsy:</p><ul><li class="half_rhythm"><div>Findings are characteristic of muscular dystrophy. Primary feature is interstitial fibrosis without muscle degeneration and regeneration, which distinguishes Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy from <a href="/books/n/gene/dbmd/">Duchenne muscular dystrophy</a> [<a class="bk_pop" href="#fcmd.REF.taniguchi.2006.489">Taniguchi et al 2006</a>].</div></li><li class="half_rhythm"><div>Immunohistochemical staining using &#x003b1;-dystroglycan antibody reveals selective deficiency of &#x003b1;-dystroglycan on the surface membrane of skeletal muscle [<a class="bk_pop" href="#fcmd.REF.hayashi.2001.115">Hayashi et al 2001</a>].</div></li></ul><p>Note: With the development of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, muscle biopsy is no longer necessary to establish the diagnosis of FCMD.</p><p><b>EMG findings</b> are characteristic of muscular dystrophy.</p></div><div id="fcmd.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FKTN</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1206/table/fcmd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figfcmdTmoleculargenetictestingusedin" rid-ob="figobfcmdTmoleculargenetictestingusedin">Table 1</a> and <a class="figpopup" href="/books/NBK1206/figure/fcmd.F1/?report=objectonly" target="object" rid-figpopup="figfcmdF1" rid-ob="figobfcmdF1">Figure 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfcmdF1" co-legend-rid="figlgndfcmdF1"><a href="/books/NBK1206/figure/fcmd.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figfcmdF1" rid-ob="figobfcmdF1"><img class="small-thumb" src="/books/NBK1206/bin/fcmd-Image001.gif" src-large="/books/NBK1206/bin/fcmd-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndfcmdF1"><h4 id="fcmd.F1"><a href="/books/NBK1206/figure/fcmd.F1/?report=objectonly" target="object" rid-ob="figobfcmdF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Diagnostic algorithm for FCMD </p></div></div><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of FCMD is broad, individuals with the distinctive findings described in <a href="#fcmd.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#fcmd.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with muscular dystrophy are more likely to be diagnosed using genomic testing (see <a href="#fcmd.Option_2">Option 2</a>).</p><div id="fcmd.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of FCMD, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm">Si<b>ngle-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> For individuals of Japanese, Korean, and/or Chinese ancestry, perform targeted analysis for the <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the entire gene.</div><div class="half_rhythm">Note: In persons of Korean descent, if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, consider <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> to detect the Korean <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.647+2084G&#x0003e;T</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A muscular dystrophy</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FKTN</i> and other genes of interest (see <a href="#fcmd.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="fcmd.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by muscular dystrophy, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="fcmd.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Fukuyama Congenital Muscular Dystrophy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1206/table/fcmd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fcmd.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> by Ethnicity Detected by Method</th></tr><tr><th headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Japanese</th><th headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Non-Japanese Asian</th><th headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Non-Asian</th></tr></thead><tbody><tr><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKTN</i></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Targeted<br />analysis</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">98%&#x000a0;<sup>3</sup></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77%&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%</td></tr><tr><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.647+2084G&#x0003e;A</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8%</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38%<br />(Korean)</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%</td></tr><tr><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.139C&#x0003e;T</a></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7%</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60%<br />(Chinese)</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8%&#x000a0;<sup>7</sup></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8%</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>9</sup></td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_fcmd.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fcmd.TF.1.1"><p class="no_margin">See <a href="/books/NBK1206/#fcmd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="fcmd.TF.1.2"><p class="no_margin">See <a href="#fcmd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="fcmd.TF.1.3"><p class="no_margin">In an analysis of 107 Japanese individuals with FCMD: 80 (75%) were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>; 25 (23%) were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a>, including nine (8%) with <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.647+2084G&#x0003e;T</a> and seven (7%) with <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.139C&#x0003e;T</a> [<a class="bk_pop" href="#fcmd.REF.kobayashi.2017.945">Kobayashi et al 2017</a>].</p></div></dd><dt>4. </dt><dd><div id="fcmd.TF.1.4"><p class="no_margin">In an analysis of 13 Korean individuals with FCMD: three (23%) were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a> variant; seven (54%) were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for c.*4392_*4393insAB185332.1, including five (38%) with <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.647+2084G&#x0003e;T</a> [<a class="bk_pop" href="#fcmd.REF.lim.2010.524">Lim et al 2010</a>].</p></div></dd><dt>5. </dt><dd><div id="fcmd.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.yang.2015.880">Yang et al [2015]</a></p></div></dd><dt>6. </dt><dd><div id="fcmd.TF.1.6"><p class="no_margin">To detect coding and noncoding pathogenic variants, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> should include methods to detect deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants, in addition to coding and flanking intronic regions. Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="fcmd.TF.1.7"><p class="no_margin">Sequence analysis will not identify the most common <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in individuals of Japanese ancestry, <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a>.</p></div></dd><dt>8. </dt><dd><div id="fcmd.TF.1.8"><p class="no_margin">Includes identification of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.1167_1168insA</a> with a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of 0.7% (2/299 individuals) [<a class="bk_pop" href="#fcmd.REF.chang.2009.560">Chang et al 2009</a>].</p></div></dd><dt>9. </dt><dd><div id="fcmd.TF.1.9"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="fcmd.Clinical_Characteristics"><h2 id="_fcmd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="fcmd.Clinical_Description"><h3>Clinical Description</h3><p>Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (FCMD) is characterized by dystrophic changes in the skeletal muscle and by CNS migration disturbances resulting in cerebral and cerebellar cortical dysplasia. The clinical features are hypotonia, weakness, and psychomotor retardation. Mild, typical, and severe phenotypes are recognized. The phenotypic spectrum ranges from a Walker-Warburg syndrome (WWS)-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> at the severe end [<a class="bk_pop" href="#fcmd.REF.manzini.2008.e231">Manzini et al 2008</a>, <a class="bk_pop" href="#fcmd.REF.chang.2009.560">Chang et al 2009</a>, <a class="bk_pop" href="#fcmd.REF.yis.2011.20">Yis et al 2011</a>] to a limb-girdle muscular dystrophy-like phenotype at the mild end [<a class="bk_pop" href="#fcmd.REF.puckett.2009.352">Puckett et al 2009</a>, <a class="bk_pop" href="#fcmd.REF.yis.2011.20">Yis et al 2011</a>, <a class="bk_pop" href="#fcmd.REF.fiorillo.2013.1010">Fiorillo et al 2013</a>].</p><p>Disease onset typically occurs in early infancy. Initial symptoms include poor suck, mildly weak cry, floppiness, and motor developmental delay. Symmetric generalized muscle weakness and hypotonia are present. Some infants exhibit poor weight gain.</p><p>Predominantly proximal hypotonia manifests as hyperextensibility of the shoulders and trunk. Limitation of hip extension, hip abduction, and knee extension is also observed and increases with time. "Puffy" cheeks and pseudohypertrophy of the calves and forearms are evident in late infancy. Muscles are hard with a fibrous texture. Deep tendon reflexes are diminished or absent after early infancy. Facial muscle involvement (myopathic facies) is obvious from age six to 12 months and increases with age [<a class="bk_pop" href="#fcmd.REF.osawa.1997">Osawa et al 1997</a>]. Open mouth, prognathism, and macroglossia become more evident in childhood. Swallowing difficulty develops after age six years.</p><p><b>Developmental delay</b> and speech delay occur in all individuals. IQ range is usually 30 to 60. In individuals with mild FCMD, the IQ is more than 35; in individuals with severe FCMD, the IQ is less than 30. The maximum development in an individual with typical FCMD often consists of dozens of spoken words, sitting without help, and sliding along the floor on the buttocks. Individuals with mild FCMD may achieve independent walking or standing. Individuals with severe FCMD may lack head control or the ability to sit independently.</p><p><b>Social development</b> of individuals with FCMD is not as severely affected as physical and mental abilities [<a class="bk_pop" href="#fcmd.REF.saito.2001">Saito &#x00026; Kobayashi 2001</a>]. Children with FCMD tend to be the favorites in their nursery, kindergarten, or primary school. Even severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with FCMD show eye contact, recognize family members, and make demands through vocalizations. Autistic features are not observed.</p><p><b>Seizures</b> occur in more than 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#fcmd.REF.yoshioka.2008.59">Yoshioka et al 2008</a>]. The average ages of onset of febrile and afebrile seizures were 5.4 and 4.6 years, respectively, in individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the Japanese <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (<a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a>). The average ages of onset of febrile and afebrile seizures were 3.6 and 3.7 years, respectively, in individuals who were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for the Japanese founder variant and an additional <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#fcmd.REF.yoshioka.2008.59">Yoshioka et al 2008</a>].</p><p><b>Ocular abnormalities</b> include refractive error (myopia and hypermetropia) in 40%-53% of individuals. Abnormalities of the retina are seen in 32% of those with more severe FCMD [<a class="bk_pop" href="#fcmd.REF.chijiiwa.1983.921">Chijiiwa et al 1983</a>, <a class="bk_pop" href="#fcmd.REF.tsutsumi.1989.413">Tsutsumi et al 1989</a>, <a class="bk_pop" href="#fcmd.REF.osawa.1997">Osawa et al 1997</a>]; however, retinal dysplasia is mild and focal.</p><p>In a few individuals with severe FCMD confirmed with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, severe ocular anomalies included microphthalmia, retinal detachment, retinal hypoplasia, cataracts, and glaucoma [<a class="bk_pop" href="#fcmd.REF.mishima.1985.155">Mishima et al 1985</a>, <a class="bk_pop" href="#fcmd.REF.hino.2001.97">Hino et al 2001</a>, <a class="bk_pop" href="#fcmd.REF.saito.2001">Saito &#x00026; Kobayashi 2001</a>, <a class="bk_pop" href="#fcmd.REF.manzini.2008.e231">Manzini et al 2008</a>, <a class="bk_pop" href="#fcmd.REF.chang.2009.560">Chang et al 2009</a>]. Of note, the characteristic ocular findings of muscle-eye-brain disease (MEBD) or WWS (e.g., anterior chamber abnormalities, glaucoma) are not present in FCMD.</p><p><b>Slowly progressive cardiac involvement</b> is characteristic of FCMD. The clinical progression of cardiac dysfunction is significantly milder than <a href="/books/n/gene/dbmd/">Duchenne muscular dystrophy</a> (DMD) [<a class="bk_pop" href="#fcmd.REF.yamamoto.2017.861">Yamamoto et al 2017</a>]. Individuals who live more than ten years tend to develop fibrosis of the myocardium, as evidenced by postmortem findings [<a class="bk_pop" href="#fcmd.REF.finsterer.2010.538">Finsterer et al 2010</a>]. In an evaluation of left ventricular (LV) function using M-mode and Doppler echocardiography in 34 individuals with FCMD, eight of 11 individuals older than age 15 years showed decreased LV systolic function [<a class="bk_pop" href="#fcmd.REF.nakanishi.2006.e1187">Nakanishi et al 2006</a>]. The brain natriuretic peptide concentration showed no correlation with age or left ventricular ejection fraction [<a class="bk_pop" href="#fcmd.REF.yamamoto.2017.861">Yamamoto et al 2017</a>].</p><p><b>Swallowing dysfunction</b> is observed in individuals with infantile FCMD (especially severe FCMD) and also in individuals older than age ten years with advanced disease. Inability to swallow leads to recurrent aspiration pneumonia and death [<a class="bk_pop" href="#fcmd.REF.hill.2004.cd004303">Hill et al 2004</a>].</p><p><a class="bk_pop" href="#fcmd.REF.murakami.2012.293">Murakami et al [2012]</a> reported sudden exacerbation of muscle weakness with marked elevation of serum creatine kinase (CK) and urinary myoglobin levels a few days after a febrile episode of viral infection, occasionally leading to death.</p><p><b>Neuropathology.</b> Examination of the brain in FCMD shows changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia caused by a defect in neuronal migration [<a class="bk_pop" href="#fcmd.REF.saito.2000.756">Saito et al 2000</a>]. These changes are similar to but typically less severe than the abnormalities described in MEBD and WWS.</p><p>Infants can show extensive areas of pachygyria over the surface of the cerebral hemispheres, a feature that is more prominent over the frontal and especially temporal lobes than the parietal and occipital lobes. A variant of polymicrogyria is frequently noted over the cortical surface of the parieto-occipital lobes (see <a href="/books/n/gene/poly/">Polymicrogyria Overview</a>).</p><p>Cerebellar cysts, lined with the molecular layer and containing leptomeningeal tissue, were observed beneath the malformed cerebellar cortex or areas of polymicrogyria [<a class="bk_pop" href="#fcmd.REF.aida.1998.317">Aida 1998</a>]. Although distinctive enough to be diagnostic of cobblestone lissencephaly, these changes do not distinguish between FCMD and other causes of MEBD or WWS.</p><p>In juvenile and adult cases, the agyric areas are more focal and restricted to the occipital lobes. Lissencephalic or agyric areas of malformed cortex may alternate with regions of polymicrogyria, based on fusion of gyri and excessive migration of glio-mesenchymal tissue extending into the subarachnoid space.</p><p>A malformed or flat ventral surface of the medulla caused by secondary hypoplasia associated with a small <i>basis pontis</i> and grooves in the spinal cord has been observed [<a class="bk_pop" href="#fcmd.REF.saito.2001">Saito &#x00026; Kobayashi 2001</a>].</p><p>In fetal cases, neurons and glia migrate through focal defects in the <i>glia limitans</i>, forming verrucous nodules, the initial manifestation of cortical dysplasia. Thus, the overmigration of CNS parenchyma into subarachnoid spaces is a pathologic process that is considered essential to the development of cortical dysplasia.</p></div><div id="fcmd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><a class="bk_pop" href="#fcmd.REF.kondoiida.1999.2303">Kondo-Iida et al [1999]</a> and <a class="bk_pop" href="#fcmd.REF.kobayashi.2017.945">Kobayashi et al [2017]</a> analyzed <i>FKTN</i> in 107 unrelated <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the Japanese <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a> show a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than do compound heterozygotes who have this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in combination with a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant on the other <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p><p>The severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, including WWS-like manifestations such as hydrocephalus and microphthalmia, was significantly more common in probands who were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> and the Japanese <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (<a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a>) [<a class="bk_pop" href="#fcmd.REF.yoshioka.2009.419">Yoshioka 2009</a>, <a class="bk_pop" href="#fcmd.REF.kobayashi.2017.945">Kobayashi et al 2017</a>] than in probands who were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the founder variant.</p><p><a class="bk_pop" href="#fcmd.REF.chang.2009.560">Chang et al [2009]</a> identified a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.1167_1168insA</a>
<i>FKTN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in four individuals with features of WWS.</p><p><a class="bk_pop" href="#fcmd.REF.godfrey.2006.603">Godfrey et al [2006]</a>, <a class="bk_pop" href="#fcmd.REF.godfrey.2007.2725">Godfrey et al [2007]</a>, <a class="bk_pop" href="#fcmd.REF.puckett.2009.352">Puckett et al [2009]</a>, <a class="bk_pop" href="#fcmd.REF.yis.2011.20">Yis et al [2011]</a>, and <a class="bk_pop" href="#fcmd.REF.fiorillo.2013.1010">Fiorillo et al [2013]</a> reported a milder LGMD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant / <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> and <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic missense variants (see <a href="#fcmd.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>).</p></div><div id="fcmd.Prevalence"><h3>Prevalence</h3><p>FCMD is second in prevalence only to DMD among all subtypes of childhood progressive muscular dystrophy in Japan, with an incidence of 0.7-1.2 per 10,000 births. Chromosomes bearing the <i>FKTN</i> Japanese <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> <a class="figpopup" href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfcmdTnotablefktnpathogenicvariants" rid-ob="figobfcmdTnotablefktnpathogenicvariants">c.*4392_*4393insAB185332.1</a> are derived from a single ancestral founder, who lived 2,000-2,500 years ago. It was found in only one of 176 chromosomes in unrelated healthy individuals [<a class="bk_pop" href="#fcmd.REF.kobayashi.1998.388">Kobayashi et al 1998</a>].</p><p>The average occurrence of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers identified in various regions of Japan is one in 188. However, in Korean populations, one <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> was detected in 935 individuals, and researchers were unable to detect any heterozygous pathogenic variants in 203 individuals of Mongolian ancestry and 766 individuals from mainland China [<a class="bk_pop" href="#fcmd.REF.watanabe.2005.344">Watanabe et al 2005</a>].</p><p>FCMD is pan ethnic, but most common in individuals of Japanese heritage.</p></div></div><div id="fcmd.Genetically_Related_Allelic_Disorde"><h2 id="_fcmd_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><b>Walker-Warburg syndrome (WWS).</b> Pathogenic variants in <i>FKTN</i> may also be associated with WWS. WWS is one of the three major phenotypes of the dystroglycanopathies (see <a href="#fcmd.Differential_Diagnosis">Differential Diagnosis</a>).</p><p>Other phenotypes associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>FKTN</i> are summarized in <a class="figpopup" href="/books/NBK1206/table/fcmd.T.other_fktnrelated_allelic_disorde/?report=objectonly" target="object" rid-figpopup="figfcmdTotherfktnrelatedallelicdisorde" rid-ob="figobfcmdTotherfktnrelatedallelicdisorde">Table 2</a>.</p><div id="fcmd.T.other_fktnrelated_allelic_disorde" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other <i>FKTN</i>-Related (Allelic) Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1206/table/fcmd.T.other_fktnrelated_allelic_disorde/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fcmd.T.other_fktnrelated_allelic_disorde_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fcmd.T.other_fktnrelated_allelic_disorde_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKTN</i>-Related (Allelic) Disorder</th><th id="hd_h_fcmd.T.other_fktnrelated_allelic_disorde_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_fcmd.T.other_fktnrelated_allelic_disorde_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dilated cardiomyopathy</td><td headers="hd_h_fcmd.T.other_fktnrelated_allelic_disorde_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dcm-ov/">Dilated Cardiomyopathy Overview</a></td></tr><tr><td headers="hd_h_fcmd.T.other_fktnrelated_allelic_disorde_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limb-girdle muscular dystrophy&#x000a0;<sup>1</sup></td><td headers="hd_h_fcmd.T.other_fktnrelated_allelic_disorde_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#fcmd.REF.godfrey.2006.603">Godfrey et al [2006]</a>, <a class="bk_pop" href="#fcmd.REF.godfrey.2007.2725">Godfrey et al [2007]</a>, <a class="bk_pop" href="#fcmd.REF.puckett.2009.352">Puckett et al [2009]</a>, <a class="bk_pop" href="#fcmd.REF.vuillaumierbarrot.2009.182">Vuillaumier-Barrot et al [2009]</a>, <a class="bk_pop" href="#fcmd.REF.yis.2011.20">Yis et al [2011]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fcmd.TF.2.1"><p class="no_margin">Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>FKTN</i> pathogenic variants have been identified in several individuals with limb-girdle muscular dystrophy type 2M.</p></div></dd></dl></div></div></div></div><div id="fcmd.Differential_Diagnosis"><h2 id="_fcmd_Differential_Diagnosis_">Differential Diagnosis</h2><p>Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (FCMD) is one of the congenital muscular dystrophies, a clinically and genetically heterogeneous group of inherited muscle disorders characterized by muscle weakness evident at birth or in early infancy. The main congenital muscular dystrophy (CMD) subtypes are laminin alpha-2 (merosin) deficiency (MDC1A), collagen VI-deficient CMD, the alpha-dystroglycanopathies (caused by pathogenic variants in <i>POMT1</i>, <i>POMT2</i>, <i>POMGNT1</i>, <i>FKTN</i>, <i>FKRP</i>, <i>LARGE1</i>, <i>ISPD</i>, <i>POMGNT2</i>, <i>DAG1</i>, <i>TMEM5</i>, <i>B3GALNT2</i>, <i>POMK</i>, <i>B4GAT1</i>, and <i>GMPPB</i>) [<a class="bk_pop" href="#fcmd.REF.godfrey.2007.2725">Godfrey et al 2007</a>, <a class="bk_pop" href="#fcmd.REF.godfrey.2011.278">Godfrey et al 2011</a>, <a class="bk_pop" href="#fcmd.REF.devisme.2012.469">Devisme et al 2012</a>, <a class="bk_pop" href="#fcmd.REF.lim.2013.337">Lim et al 2013</a>, <a class="bk_pop" href="#fcmd.REF.kang.2015">Kang et al 2015</a>, <a class="bk_pop" href="#fcmd.REF.bouchets_raphin.2016.40">Bouchet-S&#x000e9;raphin et al 2016</a>, <a class="bk_pop" href="#fcmd.REF.taniguchiikeda.2016.115">Taniguchi-Ikeda et al 2016</a>] (see <a class="figpopup" href="/books/NBK1206/table/fcmd.T.distinguishing_between_the_major/?report=objectonly" target="object" rid-figpopup="figfcmdTdistinguishingbetweenthemajor" rid-ob="figobfcmdTdistinguishingbetweenthemajor">Table 3</a>), <i>SELENON</i> (formerly <i>SEPN1</i>)-related CMD (previously known as rigid spine syndrome, or RSMD1), and <i>LMNA</i>-related CMD (L-CMD).</p><p>The three major phenotypes of the alpha-dystroglycanopathies are FCMD, Walker-Warburg syndrome (WWS), and muscle-eye-brain disease (MEBD) [<a class="bk_pop" href="#fcmd.REF.taniguchi.2003.527">Taniguchi et al 2003</a>, <a class="bk_pop" href="#fcmd.REF.voglmeir.2011.447">Voglmeir et al 2011</a>, <a class="bk_pop" href="#fcmd.REF.carss.2013.29">Carss et al 2013</a>]. The alpha-dystroglycanopathies are characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy associated with characteristic brain malformations (cobblestone [type II] lissencephaly and cerebellar malformations), eye malformations (typically involving the retina), profound intellectual disability, and early death. FCMD is milder than WWS and MEBD, particularly with respect to brain and ophthalmologic involvement [<a class="bk_pop" href="#fcmd.REF.bouchets_raphin.2016.40">Bouchet-S&#x000e9;raphin et al 2016</a>, <a class="bk_pop" href="#fcmd.REF.taniguchiikeda.2016.115">Taniguchi-Ikeda et al 2016</a>] (see <a class="figpopup" href="/books/NBK1206/table/fcmd.T.other_fktnrelated_allelic_disorde/?report=objectonly" target="object" rid-figpopup="figfcmdTotherfktnrelatedallelicdisorde" rid-ob="figobfcmdTotherfktnrelatedallelicdisorde">Table 2</a>). The alpha-dystroglycanopathies are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><div id="fcmd.T.distinguishing_between_the_major" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Distinguishing Between the Major Phenotypes of the Alpha-Dystroglycanopathies: FCMD, MEBD, and WWS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1206/table/fcmd.T.distinguishing_between_the_major/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fcmd.T.distinguishing_between_the_major_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3" colspan="3" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Severity of Findings</th><th id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4" colspan="4" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Brain MRI</th></tr><tr><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">MD</th><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eye</th><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID</th><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brain stem</th><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellum</th><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar cysts</th><th headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4" id="hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hydrocephalus</th></tr></thead><tbody><tr><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fukuyama CMD</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKTN</i></td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate to severe</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually normal; in rare cases hypoplastic</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually normal; occasionally small</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle-eye-brain disease<br />(see OMIM <a href="https://omim.org/phenotypicSeries/PS236670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS236670</a>)</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DAG1</i>&#x000a0;<sup>1</sup><br /><i>GMPPB</i>&#x000a0;<sup>2</sup><br /><i>LARGE1</i>&#x000a0;<sup>3</sup><br /><i>POMGNT1</i>&#x000a0;<sup>4</sup><br /><i>POMT1</i><br /><i>POMT2</i></td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe&#x000a0;<sup>5</sup></td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Almost always small</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Always small</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common</td></tr><tr><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Walker-Warburg syndrome<br />(see OMIM <a href="https://omim.org/phenotypicSeries/PS236670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS236670</a>)</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>B3GALNT2</i>&#x000a0;<sup>6</sup><br /><i>B4GAT1</i>&#x000a0;<sup>7</sup><br /><i>CRPPA</i> (<i>ISPD</i>)&#x000a0;<sup>8</sup><br /><i>DAG1</i>&#x000a0;<sup>9</sup><br /><i>FKRP</i>&#x000a0;<sup>10</sup><br /><i>FKTN</i><br /><i>GMPPB</i>&#x000a0;<sup>2</sup><br /><i>LARGE1</i>&#x000a0;<sup>3</sup><br /><i>POMGNT1</i>&#x000a0;<sup>4</sup><br /><i>POMGNT2</i>&#x000a0;<sup>11</sup><br /><i>POMK</i>&#x000a0;<sup>12</sup><br /><i>POMT1</i>&#x000a0;<sup>13</sup><br /><i>POMT2</i>&#x000a0;<sup>14</sup><br /><i>RXYLT1</i> (<i>TMEM5</i>)&#x000a0;<sup>15</sup></td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe&#x000a0;<sup>16</sup></td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_3 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very small &#x00026; kinked at<br />junction of midbrain &#x00026; pons</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very small</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed</td><td headers="hd_h_fcmd.T.distinguishing_between_the_major_1_1_1_4 hd_h_fcmd.T.distinguishing_between_the_major_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Almost universal</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ID = intellectual disability; MD = muscle dystrophy</p></div></dd><dt>1. </dt><dd><div id="fcmd.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.signorino.2018.266">Signorino et al [2018]</a></p></div></dd><dt>2. </dt><dd><div id="fcmd.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.astrea.2018">Astrea et al [2018]</a></p></div></dd><dt>3. </dt><dd><div id="fcmd.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.meilleur.2014.425">Meilleur et al [2014]</a></p></div></dd><dt>4. </dt><dd><div id="fcmd.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.fu.2017.7056">Fu et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="fcmd.TF.3.5"><p class="no_margin">Severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopia, congenital glaucoma, pallor of the optic discs, retinal hypoplasia</p></div></dd><dt>6. </dt><dd><div id="fcmd.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.buysse.2013.1746">Buysse et al [2013]</a>, <a class="bk_pop" href="#fcmd.REF.stevens.2013.354">Stevens et al [2013]</a></p></div></dd><dt>7. </dt><dd><div id="fcmd.TF.3.7"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.buysse.2013.1746">Buysse et al [2013]</a></p></div></dd><dt>8. </dt><dd><div id="fcmd.TF.3.8"><p class="no_margin">Mutation of <i>CRPPA</i> (<i>ISPD</i>) causes severe WWS but is also a cause of the milder forms such as LGMD [<a class="bk_pop" href="#fcmd.REF.cirak.2013.269">Cirak et al 2013</a>].</p></div></dd><dt>9. </dt><dd><div id="fcmd.TF.3.9"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.riemersma.2015.2177">Riemersma et al [2015]</a></p></div></dd><dt>10. </dt><dd><div id="fcmd.TF.3.10"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.yoshioka.2017.869">Yoshioka et al [2017]</a></p></div></dd><dt>11. </dt><dd><div id="fcmd.TF.3.11"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.manzini.2012.541">Manzini et al [2012]</a></p></div></dd><dt>12. </dt><dd><div id="fcmd.TF.3.12"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.di_costanzo.2014.5781">Di Costanzo et al [2014]</a></p></div></dd><dt>13. </dt><dd><div id="fcmd.TF.3.13"><p class="no_margin">Kang et al 2015</p></div></dd><dt>14. </dt><dd><div id="fcmd.TF.3.14"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.kitamura.2016.931">Kitamura et al [2016]</a></p></div></dd><dt>15. </dt><dd><div id="fcmd.TF.3.15"><p class="no_margin"><a class="bk_pop" href="#fcmd.REF.praissman.2016.5">Praissman et al [2016]</a></p></div></dd><dt>16. </dt><dd><div id="fcmd.TF.3.16"><p class="no_margin">Microphthalmia, retinal detachment, retinal hypoplasia, anterior chamber malformation, cataracts</p></div></dd></dl></div></div></div></div><div id="fcmd.Management"><h2 id="_fcmd_Management_">Management</h2><p>A consensus statement on standard of care for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophies (CMD) has been published [<a class="bk_pop" href="#fcmd.REF.wang.2010">Wang et al 2010</a>] (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207780/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>). <a class="bk_pop" href="#fcmd.REF.kang.2015">Kang et al [2015]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388744/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>) have also published an evidence-based guideline including management guidelines for individuals with CMD.</p><div id="fcmd.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (FCMD), the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Neurologic evaluation, including EEG and brain MRI</div></li><li class="half_rhythm"><div>Developmental assessment including assessment of motor skills, cognition, and speech</div></li><li class="half_rhythm"><div>Physical therapy evaluation of joint range of motion</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Feeding and swallowing assessment in individuals who lack head control or the ability to sit without support</div></li><li class="half_rhythm"><div>Assessment of caloric intake and nutritional status</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="fcmd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>There is no curative treatment for FCMD. Appropriate multidisciplinary management can prolong survival and improve the quality of life for individuals with FCMD.</p><p>Treatment includes the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Physical therapy and stretching exercises to promote mobility and prevent contractures</div></li><li class="half_rhythm"><div class="half_rhythm">When scoliosis is present, spinal fusion to preserve breathing function and improve sitting balance [<a class="bk_pop" href="#fcmd.REF.takaso.2010.493">Takaso et al 2010</a>, <a class="bk_pop" href="#fcmd.REF.hino.2017.613">Hino et al 2017</a>, <a class="bk_pop" href="#fcmd.REF.saito.2017.658">Saito et al 2017</a>]</div></li><li class="half_rhythm"><div class="half_rhythm">Use of mechanical assistance such as long leg braces to maintain standing posture and wheelchairs to help mobility</div></li><li class="half_rhythm"><div class="half_rhythm">Use of respiratory aids such as nasal intermittent positive pressure ventilator when indicated [<a class="bk_pop" href="#fcmd.REF.sato.2016.324">Sato et al 2016</a>]</div><div class="half_rhythm">Note: Noninvasive ventilation is offered, particularly at night, before respiratory distress becomes acute.</div></li><li class="half_rhythm"><div class="half_rhythm">Prompt treatment of acute respiratory tract infections; particularly important, as these infections are the most common cause of hospital admissions and death in people with FCMD</div></li><li class="half_rhythm"><div class="half_rhythm">Antiepileptic drugs when indicated</div></li><li class="half_rhythm"><div class="half_rhythm">Medical and/or surgical treatment for gastroesophageal reflux when indicated</div></li><li class="half_rhythm"><div class="half_rhythm">Gastrostomy tube placement when indicated to assure adequate caloric intake</div></li><li class="half_rhythm"><div class="half_rhythm">Cardiomyopathy treatment as per cardiologist</div></li></ul></div><div id="fcmd.Surveillance"><h3>Surveillance</h3><p>The following surveillance based on evidence-based guidelines [<a class="bk_pop" href="#fcmd.REF.kang.2015">Kang et al 2015</a>] is intended to promote growth and potential development, mitigate comorbidities, optimize function, and limit mortality while maximizing quality of life:</p><ul><li class="half_rhythm"><div>Clinical evaluation of individuals with seizures at least every three months and EEG every six months</div></li><li class="half_rhythm"><div>Monitoring of respiratory function in individuals with advanced FCMD who are older than age ten years. Those who survive beyond age 20 years may require tracheostomy or noninvasive respiratory support.</div></li><li class="half_rhythm"><div>Monitoring of myocardial involvement by chest x-ray, ECG, and echocardiography in individuals older than age ten years</div></li><li class="half_rhythm"><div>Observation/evaluation of gastrointestinal function by a qualified specialist, using a video-fluoroscopic swallow assessment, upper-gastrointestinal tract image, and pH monitor for gastroesophageal reflux</div></li><li class="half_rhythm"><div>Monitoring for foot deformities and scoliosis</div></li></ul></div><div id="fcmd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#fcmd.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="fcmd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><b>Antisense oligonucleotide therapy.</b>
<a class="bk_pop" href="#fcmd.REF.taniguchiikeda.2011.127">Taniguchi-Ikeda et al [2011]</a> reported that introduction of targeted antisense oligonucleotides in cell cultures of individuals with FCMD and in model mice rescued normal fukutin <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> expression and protein production. Their work has demonstrated the promise of <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> modulation therapy as a radical clinical treatment for FCMD.</p><p><b>Supplementation therapy.</b>
<a class="bk_pop" href="#fcmd.REF.kanagawa.2016.2209">Kanagawa et al [2016]</a> reported that ribitol 5-phosphate is a functional glycan unit in mammals and that defects in its post-translational modification pathway are a cause of <i>ISPD-</i>, <i>FKRP-</i>, and <i>FKTN</i>-alpha-dystroglycanopathies. Since ISPD deficiency leads to a loss of or severe reduction in cellular CDP-ribitol, the supplementation of CDP-ribitol may be effective in treating FCMD. <a class="bk_pop" href="#fcmd.REF.gerin.2016.11534">Gerin et al [2016]</a> showed that ribitol supplementation to fibroblasts from individuals with <i>ISPD</i> pathogenic variants leads to a partial rescue of alpha-dystroglycan glycosylation.</p><p><b>Gene therapy.</b> The effectiveness of recombinant adeno-associated virus serotype 9-mediated fukutin- and <i>FKRP</i>-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> delivery has been demonstrated using FCMD and LGMD model mice, respectively [<a class="bk_pop" href="#fcmd.REF.kanagawa.2013.3003">Kanagawa et al 2013</a>, <a class="bk_pop" href="#fcmd.REF.xu.2013.1832">Xu et al 2013</a>]. Earlier intervention would be highly preferred [<a class="bk_pop" href="#fcmd.REF.vannoy.2017.31">Vannoy et al 2017</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="fcmd.Genetic_Counseling"><h2 id="_fcmd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="fcmd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Fukuyama <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy (FCMD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="fcmd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>FKTN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with FCMD are not known to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>FKTN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="fcmd.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>FKTN</i> pathogenic variants in the family.</p></div><div id="fcmd.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="fcmd.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FKTN</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="fcmd.Resources"><h2 id="_fcmd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cure CMD</b></div><div>19401 South Vermont Avenue</div><div>Suite J100</div><div>Torrance CA 90502</div><div><b>Phone:</b> 323-250-2399</div><div><b>Fax:</b> 310-684-2023</div><div><b>Email:</b> info@curecmd.org</div><div><a href="http://www.curecmd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.curecmd.org</a></div></li><li class="half_rhythm"><div><b>European Neuromuscular Centre (ENMC)</b></div><div>Lt Gen van Heutszlaan 6</div><div>3743 JN Baarn</div><div>Netherlands</div><div><b>Phone:</b> 31 35 5480481</div><div><b>Fax:</b> 31 35 5480499</div><div><b>Email:</b> enmc@enmc.org</div><div><a href="http://www.enmc.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.enmc.org</a></div></li><li class="half_rhythm"><div><b>Japan Muscular Dystrophy Association</b></div><div>3-43-11 Fukushi Zaidan Bldg</div><div> Tokyo 170-0005</div><div>Japan</div><div><b>Phone:</b> 81-3-6907-3521</div><div><a href="http://www.jmda.or.jp/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.jmda.or.jp</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>Congenital Muscle Disease International Registry (CMDIR)</b></div><div><i>The CMDIR is a patient self-report registry with the goal to register the global <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscle disease population including persons with congenital myopathy, congenital muscular dystrophy, and congenital myasthenic syndrome. The CMDIR registers <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of all ages with symptoms from birth through late onset (limb-girdle). Registrants will receive educational information and connections to others in the CMD community, and will be contacted about potential participation in clinical trials for their CMD subtype.</i></div><div>19401 South Vermont Avenue</div><div>Suite J100</div><div>Torrance CA 90502</div><div><b>Phone:</b> 323-250-2399</div><div><b>Fax:</b> 310-684-2023</div><div><b>Email:</b> counselor@cmdir.org; sarah.foye@cmdir.org</div><div><a href="http://www.cmdir.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmdir.org</a></div></li></ul></div><div id="fcmd.Molecular_Genetics"><h2 id="_fcmd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="fcmd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Fukuyama Congenital Muscular Dystrophy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1206/table/fcmd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fcmd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_fcmd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_fcmd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_fcmd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_fcmd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_fcmd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_fcmd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_fcmd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2218" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FKTN</i></a></td><td headers="hd_b_fcmd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2218" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q31<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_fcmd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75072" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fukutin</a></td><td headers="hd_b_fcmd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/FKTN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FKTN homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_fcmd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FKTN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FKTN</a></td><td headers="hd_b_fcmd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FKTN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FKTN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="fcmd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="fcmd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Fukuyama Congenital Muscular Dystrophy (<a href="/omim/253800,607440" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1206/table/fcmd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fcmd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/253800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">253800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607440" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607440</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FUKUTIN; FKTN</td></tr></tbody></table></div></div><div id="fcmd.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b> The dystroglycanopathy genes <i>FKTN</i>, <i>FKRP</i>, and <i>ISPD</i> encode essential enzymes for the synthesis of the structure: fukutin and FKRP transfer ribitol-phosphate onto sugar chains of alpha-dystroglycan, and ISPD synthesizes CDP-ribitol, a donor substrate for fukutin and FKRP [<a class="bk_pop" href="#fcmd.REF.kanagawa.2016.2209">Kanagawa et al 2016</a>]. Fukutin, FKRP, and ISPD are directly involved in the synthesis of the tandem RboP: fukutin and FKRP are RboP transferases, and ISPD is involved in cellular CDP-ribitol synthesis [<a class="bk_pop" href="#fcmd.REF.kanagawa.2016.2209">Kanagawa et al 2016</a>]. In addition, TMEM5 is a UDP-xylosyl transferase enzyme for modification of ribitol that is in a phosphodiester linkage to the core M3 glycan on alpha-dystroglycan [<a class="bk_pop" href="#fcmd.REF.praissman.2016.5">Praissman et al 2016</a>].</p><p><b>Mechanism of disease causation.</b> Loss of function. FCMD is a disease of ribitol-phosphate deficiency.</p><div id="fcmd.T.notable_fktn_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Notable <i>FKTN</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1206/table/fcmd.T.notable_fktn_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fcmd.T.notable_fktn_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001079802.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001079802<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001073270.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001073270<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1167_1168insA</td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe390IlefsTer14</td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> [<a class="bk_pop" href="#fcmd.REF.chang.2009.560">Chang et al 2009</a>]</td></tr><tr><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006731.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006731<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.647+2084G&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg216SerfsTer10</td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in Korea [<a class="bk_pop" href="#fcmd.REF.lim.2010.524">Lim et al 2010</a>]; 2nd most common variant in Japan [<a class="bk_pop" href="#fcmd.REF.kobayashi.2017.945">Kobayashi et al 2017</a>]</td></tr><tr><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006731.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006731<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_006722.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006722<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.*4392_*4393insAB185332.1&#x000a0;<sup>2,&#x000a0;3</sup></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in Japan [<a class="bk_pop" href="#fcmd.REF.kobayashi.1998.388">Kobayashi et al 1998</a>]</td></tr><tr><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001079802.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001079802<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.139C&#x0003e;T</td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg47Ter</td><td headers="hd_h_fcmd.T.notable_fktn_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3rd most common variant in Japan [<a class="bk_pop" href="#fcmd.REF.kobayashi.2017.945">Kobayashi et al 2017</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="fcmd.TF.4.1"><p class="no_margin">Deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> variant of <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> that activates a pseudoexon</p></div></dd><dt>2. </dt><dd><div id="fcmd.TF.4.2"><p class="no_margin">A 3-kb retrotransposon <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of tandemly repeated sequences in the 3' untranslated region [<a class="bk_pop" href="#fcmd.REF.kato.2004.54">Kato et al 2004</a>]. Asterisk denotes a variant in the 3' UTR; the number indicates the nucleotide position beyond the stop codon. <a href="https://www.ncbi.nlm.nih.gov/nuccore/AB185332.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AB185332<wbr style="display:inline-block"></wbr>​.1</a> is the accession number of the sequence of the inserted retrotransposon.</p></div></dd><dt>3. </dt><dd><div id="fcmd.TF.4.3"><p class="no_margin">Also known as <a href="/nuccore/NM_001079802.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001079802<wbr style="display:inline-block"></wbr>​.1</a>:c.*4392_4393ins3062</p></div></dd></dl></div></div></div></div></div><div id="fcmd.References"><h2 id="_fcmd_References_">References</h2><div id="fcmd.Published_Guidelines__Consensus_Sta"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kang.2015">Kang PB, Morrison L, Iannaccone ST, Graham RJ, B&#x000f6;nnemann CG, Rutkowski A, Hornyak J, Wang CH, North K, Oskoui M, Getchius TS, Cox JA, Hagen EE, Gronseth G, Griggs RC; Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular &#x00026; Electrodiagnostic Medicine. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy. Available <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388744/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2015. Accessed 6-27-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.wang.2010">Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, Aloysius A, Bash RO, B&#x000e9;roud C, Bertini E, Bushby K, Cohn RD, Connolly AM, Deconinck N, Desguerre I, Eagle M, Estournet-Mathiaud B, Ferreiro A, Fujak A, Goemans N, Iannaccone ST, Jouinot P, Main M, Melacini P, Mueller-Felber W, Muntoni F, Nelson LL, Rahbek J, Quijano-Roy S, Sewry C, Storhaug K, Simonds A, Tseng B, Vajsar J, Vianello A, Zeller R; International Standard of Care Committee for Congenital Muscular Dystrophy. Consensus statement on standard of care for congenital muscular dystrophies. Available <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207780/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2010. Accessed 6-27-19. [<a href="/pmc/articles/PMC5207780/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5207780</span></a>] [<a href="/pubmed/21078917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21078917</span></a>]</div></li></ul></div><div id="fcmd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.aida.1998.317">Aida N. Fukuyama congenital muscular dystrophy: a neuroradiologic review. <span><span class="ref-journal">J Magn Reson Imaging. </span>1998;<span class="ref-vol">8</span>:317–26.</span> [<a href="/pubmed/9562058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9562058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.aida.1994.1755">Aida N, Yagishita A, Takada K, Katsumata Y. Cerebellar MR in Fukuyama congenital muscular dystrophy: polymicrogyria with cystic lesions. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>1994;<span class="ref-vol">15</span>:1755–9.</span> [<a href="/pubmed/7847224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7847224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.astrea.2018">Astrea G, Romano A, Angelini C, Antozzi CG, Barresi R, Battini R, Battisti C, Bertini E, Bruno C, Cassandrini D, Fanin M, Fattori F, Fiorillo C, Guerrini R, Maggi L, Mercuri E, Morani F, Mora M, Moro F, Pezzini I, Picillo E, Pinelli M, Politano L, Rubegni A, Sanseverino W, Savarese M, Striano P, Torella A, Trevisan CP, Trovato R, Zaraieva I, Muntoni F, Nigro V, D'Amico A, Santorelli FM, et al. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. Orphanet J Rare Dis. 2018;26;13:170. [<a href="/pmc/articles/PMC6158856/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6158856</span></a>] [<a href="/pubmed/30257713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30257713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.bouchets_raphin.2016.40">Bouchet-S&#x000e9;raphin C, Chelbi-Viallon M, Vuillaumier-Barrot S, Seta N. Genes of alpha-dystroglycanopathies in 2016. Article in French. <span><span class="ref-journal">Med Sci (Paris). </span>2016;<span class="ref-vol">32</span>:40–5.</span> [<a href="/pubmed/27869076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27869076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.buysse.2013.1746">Buysse K, Riemersma M, Powell G, van Reeuwijk J, Chitayat D, Roscioli T, Kamsteeg EJ, van den Elzen C, van Beusekom E, Blaser S, Babul-Hirji R, Halliday W, Wright GJ, Stemple DL, Lin YY, Lefeber DJ, van Bokhoven H. Missense mutations in beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:1746–54.</span> [<a href="/pmc/articles/PMC3613162/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3613162</span></a>] [<a href="/pubmed/23359570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23359570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.carss.2013.29">Carss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore SA, Messina S, Bertini E, B&#x000f6;nnemann CG, Abdenur JE, Grosmann CM, Kesari A, Punetha J, Quinlivan R, Waddell LB, Young HK, Wraige E, Yau S, Brodd L, Feng L, Sewry C, MacArthur DG, North KN, Hoffman E, Stemple DL, Hurles ME, van Bokhoven H, Campbell KP, Lefeber DJ, Lin YY, Muntoni F, et al.  Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of alpha-dystroglycan. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:29–41.</span> [<a href="/pmc/articles/PMC3710768/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3710768</span></a>] [<a href="/pubmed/23768512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23768512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.chang.2009.560">Chang W, Winder TL, LeDuc CA, Simpson LL, Millar WS, Dungan J, Ginsberg N, Plaga S, Moore SA, Chung WK. Founder fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. <span><span class="ref-journal">Prenat Diagn. </span>2009;<span class="ref-vol">29</span>:560–9.</span> [<a href="/pmc/articles/PMC2735827/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2735827</span></a>] [<a href="/pubmed/19266496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19266496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.chijiiwa.1983.921">Chijiiwa T, Nishimura M, Inomata H, Yamana T, Narazaki O, Kurokawa T. Ocular manifestations of congenital muscular dystrophy (Fukuyama type). <span><span class="ref-journal">Ann Ophthalmol. </span>1983;<span class="ref-vol">15</span>:921–3, 926-8.</span> [<a href="/pubmed/6651132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6651132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.cirak.2013.269">Cirak S, Foley AR, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, N&#x000fc;rnberg P, Michele DE, Plagnol V, Hurles M, Moore SA, Sewry CA, Campbell KP, Voit T, Muntoni F, et al.  ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:269–81.</span> [<a href="/pmc/articles/PMC3562076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3562076</span></a>] [<a href="/pubmed/23288328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23288328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.devisme.2012.469">Devisme L, Bouchet C, Gonzal&#x000e8;s M, Alanio E, Bazin A, Bessi&#x000e8;res B, Bigi N, Blanchet P, Bonneau D, Bonni&#x000e8;res M, Bucourt M, Carles D, Clarisse B, Delahaye S, Fallet-Bianco C, Figarella-Branger D, Gaillard D, Gasser B, Delezoide AL, Guimiot F, Joubert M, Laurent N, Laquerri&#x000e8;re A, Liprandi A, Loget P, Marcorelles P, Martinovic J, Menez F, Patrier S, Pelluard F, Perez MJ, Rouleau C, Triau S, Atti&#x000e9;-Bitach T, Vuillaumier-Barrot S, Seta N, Encha-Razavi F. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:469–82.</span> [<a href="/pubmed/22323514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22323514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.di_costanzo.2014.5781">Di Costanzo S, Balasubramanian A, Pond HL, Rozkalne A, Pantaleoni C, Saredi S, Gupta VA, Sunu CM, Yu TW, Kang PB, Salih MA, Mora M, Gussoni E, Walsh CA, Manzini MC. POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:5781–92.</span> [<a href="/pmc/articles/PMC4189906/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4189906</span></a>] [<a href="/pubmed/24925318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24925318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.finsterer.2010.538">Finsterer J, Ramaciotti C, Wang CH, Wahbi K, Rosenthal D, Duboc D, Melacini P. Cardiac findings in congenital muscular dystrophies. <span><span class="ref-journal">Pediatrics. </span>2010;<span class="ref-vol">126</span>:538–45.</span> [<a href="/pubmed/20679303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20679303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.fiorillo.2013.1010">Fiorillo C, Moro F, Astrea G, Morales MA, Baldacci J, Marchese M, Scapolan S, Bruno C, Battini R, Santorelli FM. Novel mutations in the fukutin gene in a boy with asymptomatic hyperCKemia. <span><span class="ref-journal">Neuromuscul Disord. </span>2013;<span class="ref-vol">23</span>:1010–5.</span> [<a href="/pubmed/24144914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24144914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.fu.2017.7056">Fu X, Yang H, Jiao H, Wang S, Liu A, Li X, Xiao J, Yang Y, Wu X, Xiong H. Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencing. <span><span class="ref-journal">Sci Rep. </span>2017;<span class="ref-vol">7</span>:7056.</span> [<a href="/pmc/articles/PMC5539251/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5539251</span></a>] [<a href="/pubmed/28765568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28765568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.gerin.2016.11534">Gerin I, Ury B, Breloy I, Bouchet-Seraphin C, Bols&#x000e9;e J, Halbout M, Graff J, Vertommen D, Muccioli GG, Seta N, Cuisset JM, Dabaj I, Quijano-Roy S, Grahn A, Van Schaftingen E, Bommer GT. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto &#x003b1;-dystroglycan. <span><span class="ref-journal">Nat Commun. </span>2016;<span class="ref-vol">7</span>:11534.</span> [<a href="/pmc/articles/PMC4873967/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4873967</span></a>] [<a href="/pubmed/27194101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27194101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.godfrey.2007.2725">Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, Jimenez-Mallebrera C, Mercuri E, Manzur AY, Kinali M, Torelli S, Brown SC, Sewry CA, Bushby K, Topaloglu H, North K, Abbs S, Muntoni F. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:2725–35.</span> [<a href="/pubmed/17878207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17878207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.godfrey.2006.603">Godfrey C, Escolar D, Brockington M, Clement EM, Mein R, Jimenez-Mallebrera C, Torelli S, Feng L, Brown SC, Sewry CA, Rutherford M, Shapira Y, Abbs S, Muntoni F. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">60</span>:603–10.</span> [<a href="/pubmed/17044012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17044012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.godfrey.2011.278">Godfrey C, Foley AR, Clemen E, Muntoni F. Dystroglycanopathies: coming into focus. <span><span class="ref-journal">Curr Opin Genet Dev. </span>2011;<span class="ref-vol">21</span>:278–85.</span> [<a href="/pubmed/21397493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21397493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.hayashi.2001.115">Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">57</span>:115–21.</span> [<a href="/pubmed/11445638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11445638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.hill.2004.cd004303">Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2004;<span class="ref-vol">2</span>:CD004303.</span> [<a href="/pubmed/15106246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15106246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.hino.2017.613">Hino K, Fukuda M, Morino T, Ogata T, Ito M, Ishii E. Spinal fusion in a patient with Fukuyama congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2017;<span class="ref-vol">39</span>:613–6.</span> [<a href="/pubmed/28318781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28318781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.hino.2001.97">Hino N, Kobayashi M, Shibata N, Yamamoto T, Saito K, Osawa M. Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2001;<span class="ref-vol">23</span>:97–107.</span> [<a href="/pubmed/11248458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11248458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kanagawa.2016.2209">Kanagawa M, Kobayashi K, Tajiri M, Manya H, Kuga A, Yamaguchi Y, Akasaka-Manya K, Furukawa JI, Mizuno M, Kawakami H, Shinohara Y, Wada Y, Endo T, Toda T. Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. <span><span class="ref-journal">Cell Rep. </span>2016;<span class="ref-vol">14</span>:2209–23.</span> [<a href="/pubmed/26923585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26923585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kanagawa.2013.3003">Kanagawa M, Yu CC, Ito C, Fukada S, Hozoji-Inada M, Chiyo T, Kuga A, Matsuo M, Sato K, Yamaguchi M, Ito T, Ohtsuka Y, Katanosaka Y, Miyagoe-Suzuki Y, Naruse K, Kobayashi K, Okada T, Takeda S, Toda T. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:3003–15.</span> [<a href="/pubmed/23562821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23562821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kang.2015.1369">Kang PB, Morrison L, Iannaccone ST, Graham RJ, B&#x000f6;nnemann CG, Rutkowski A, Hornyak J, Wang CH, North K, Oskoui M, Getchius TS, Cox JA, Hagen EE, Gronseth G, Griggs RC, et al.  Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular &#x00026; Electrodiagnostic Medicine. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:1369–78.</span> [<a href="/pmc/articles/PMC4388744/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4388744</span></a>] [<a href="/pubmed/25825463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25825463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kato.2004.54">Kato R, Kawamura J, Sugawara H, Niikawa N, Matsumoto N. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">127A</span>:54–7.</span> [<a href="/pubmed/15103718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15103718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kato.2000.385">Kato T, Funahashi M, Matsui A, Takashima S, Suzuki Y. MRI of disseminated developmental dysmyelination in Fukuyama type of CMD. <span><span class="ref-journal">Pediatr Neurol. </span>2000;<span class="ref-vol">23</span>:385–8.</span> [<a href="/pubmed/11118792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11118792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kato.2010.s127">Kato Z, Morimoto M, Orii KE, Kato T, Kondo N. Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy. <span><span class="ref-journal">Pediatr Radiol. </span>2010;<span class="ref-vol">40</span>:S127–9.</span> [<a href="/pubmed/20571791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20571791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kato.2006.261">Kato Z, Saito K, Isogai K, Kondo N. Magnetic resonance imaging and spectroscopy in Fukuyama-type congenital muscular dystrophy. <span><span class="ref-journal">J Pediatr Neurol. </span>2006;<span class="ref-vol">4</span>:261–4.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kitamura.2016.931">Kitamura Y, Kondo E, Urano M, Aoki R, Saito K. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders. <span><span class="ref-journal">J Hum Genet. </span>2016;<span class="ref-vol">61</span>:931–42.</span> [<a href="/pubmed/27357428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27357428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kobayashi.2017.945">Kobayashi K, Kato R, Kondo-Iida E, Taniguchi-Ikeda M, Osawa M, Saito K, Toda T. Deep-intronic variant of fukutin is the most prevalent point mutation of Fukuyama congenital muscular dystrophy in Japan. <span><span class="ref-journal">J Hum Genet. </span>2017;<span class="ref-vol">62</span>:945–8.</span> [<a href="/pubmed/28680109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28680109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kobayashi.1998.388">Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, Hamano K, Sakakihara Y, Nonaka I, Nakagome Y, Kanazawa I, Nakamura Y, Tokunaga K, Toda T. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">394</span>:388–92.</span> [<a href="/pubmed/9690476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9690476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.kondoiida.1999.2303">Kondo-Iida E, Kobayashi K, Watanabe M, Sasaki J, Kumagai T, Koide H, Saito K, Osawa M, Nakamura Y, Toda T. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:2303–9.</span> [<a href="/pubmed/10545611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10545611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.lim.2010.524">Lim BC, Ki C-S, Kim J-W, Cho A, Kim MJ, Hwang H, Kim KJ, Hwang YS, Park WY, Lim Y-J, Kim IO, Lee JS, Chae JH. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea. <span><span class="ref-journal">Neuromuscul Disord. </span>2010;<span class="ref-vol">20</span>:524–30.</span> [<a href="/pubmed/20620061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20620061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.lim.2013.337">Lim BC, Lee S, Shin JY, Hwang H, Kim KJ, Hwang YS, Seo JS, Kim JI, Chae JH. Molecular diagnosis of congenital muscular dystrophies with defective glycosylation of alpha-dystroglycan using next-generation sequencing technology. <span><span class="ref-journal">Neuromuscul Disord. </span>2013;<span class="ref-vol">23</span>:337–44.</span> [<a href="/pubmed/23453855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23453855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.manzini.2008.e231">Manzini MC, Gleason D, Chang BS, Hill RS, Barry BJ, Partlow JN, Poduri A, Currier S, Galvin-Parton P, Shapiro LR, Schmidt K, Davis JG, Basel-Vanagaite L, Seidahmed MZ, Salih MAM, Dobyns WB, Walsh CA. Ethnically diverse causes of Walker-Warburg syndrome (WWS): FCMD mutations are a more common cause of WWS outside of the Middle East. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:E231–41.</span> [<a href="/pmc/articles/PMC2577713/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2577713</span></a>] [<a href="/pubmed/18752264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18752264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.manzini.2012.541">Manzini MC, Tambunan DE, Hill RS, Yu TW, Maynard TM, Heinzen EL, Shianna KV, Stevens CR, Partlow JN, Barry BJ, Rodriguez J, Gupta VA, Al-Qudah AK, Eyaid WM, Friedman JM, Salih MA, Clark R, Moroni I, Mora M, Beggs AH, Gabriel SB, Walsh CA. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:541–7.</span> [<a href="/pmc/articles/PMC3512000/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3512000</span></a>] [<a href="/pubmed/22958903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22958903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.meilleur.2014.425">Meilleur KG, Zukosky K, Medne L, Fequiere P, Powell-Hamilton N, Winder TL, Alsaman A, El-Hattab AW, Dastgir J, Hu Y, Donkervoort S, Golden JA, Eagle R, Finkel R, Scavina M, Hood IC, Rorke-Adams LB, B&#x000f6;nnemann CG. Clinical, pathologic, and mutational spectrum of dystroglycanopathy caused by LARGE mutations. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2014;<span class="ref-vol">73</span>:425–41.</span> [<a href="/pmc/articles/PMC5113964/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5113964</span></a>] [<a href="/pubmed/24709677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24709677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.mishima.1985.155">Mishima H, Hirata H, Ono H, Choshi K, Nishi Y, Fukuda K. A Fukuyama type of congenital muscular dystrophy associated with atypical gyrate atrophy of the choroid and retina. A case report. <span><span class="ref-journal">Acta Ophthalmol (Copenh). </span>1985;<span class="ref-vol">63</span>:155–9.</span> [<a href="/pubmed/4003043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4003043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.murakami.2012.293">Murakami T, Ishigaki K, Shirakawa S, Ikenaka H, Sakauchi M, Osawa M. Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2012;<span class="ref-vol">34</span>:293–7.</span> [<a href="/pubmed/21726969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21726969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.nakanishi.2006.e1187">Nakanishi T, Sakauchi M, Kaneda Y, Tomimatsu H, Saito K, Nakazawa M, Osawa M. Cardiac involvement in Fukuyama-type congenital muscular dystrophy. <span><span class="ref-journal">Pediatrics. </span>2006;<span class="ref-vol">117</span>:e1187–92.</span> [<a href="/pubmed/16717122" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16717122</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.osawa.1997">Osawa M, Sumida S, Suzuki N, Arai Y, Ikenaka H, Murasugi H, Shishikura K, Suzuki H, Saito K, Fukuyama Y. Fukuyama type congenital muscular dystrophy. In: Fukuyama Y, Osawa M, Saito K, eds. <em>Congenital Muscular Dystrophies</em>. Amsterdam, Netherlands: Elsevier Science; 1997:31-68.</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.praissman.2016.5">Praissman JL, Willer T, Sheikh MO, Toi A, Chitayat D, Lin YY, Lee H, Stalnaker SH, Wang S, Prabhakar PK, Nelson SF, Stemple DL, Moore SA, Moremen KW, Campbell KP, Wells L. The functional O-mannose glycan on alpha-dystroglycan contains a phospho-ribitol primed for matriglycan addition. <span><span class="ref-journal">Elife. </span>2016:5.</span> [<a href="/pmc/articles/PMC4924997/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4924997</span></a>] [<a href="/pubmed/27130732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27130732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.puckett.2009.352">Puckett RL, Moore SA, Winder TL, Willer T, Romansky SG, Covault KK, Campbell KP, Abdenur JE. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:352–6.</span> [<a href="/pmc/articles/PMC2698593/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2698593</span></a>] [<a href="/pubmed/19342235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19342235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.riemersma.2015.2177">Riemersma M, Mandel H, van Beusekom E, Gazzoli I, Roscioli T, Eran A, Gershoni-Baruch R, Gershoni M, Pietrokovski S, Vissers LE, Lefeber DJ, Willemsen MA, Wevers RA, van Bokhoven H. Absence of &#x003b1;- and &#x003b2;-dystroglycan is associated with Walker-Warburg syndrome. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:2177–82.</span> [<a href="/pubmed/25934851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25934851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.saito.2001">Saito K, Kobayashi M. Fukuyama congenital muscular dystrophy. In: Emery AEH, ed. <em>Muscular Dystrophies</em>. Oxford, UK: Oxford University Press; 2001:39-54.</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.saito.2017.658">Saito W, Namba T, Inoue G, Imura T, Miyagi M, Nakazawa T, Shirasawa E, Uchida K, Takaso M. Spinal correction in patients with Fukuyama congenital muscular dystrophy. <span><span class="ref-journal">J Orthop Sci. </span>2017;<span class="ref-vol">22</span>:658–64.</span> [<a href="/pubmed/28325699" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28325699</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.saito.2000.756">Saito Y, Mizuguchi M, Oka A, Takashima S. Fukutin protein is expressed in neurons of the normal developing human brain but is reduced in Fukuyama-type congenital muscular dystrophy brain. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">47</span>:756–64.</span> [<a href="/pubmed/10852541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10852541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.sato.2016.324">Sato T, Murakami T, Ishiguro K, Shichiji M, Saito K, Osawa M, Nagata S, Ishigaki K. Respiratory management of patients with Fukuyama congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2016;<span class="ref-vol">38</span>:324–30.</span> [<a href="/pubmed/26363734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26363734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.signorino.2018.266">Signorino G, Covaceuszach S, Bozzi M, H&#x000fc;bner W, M&#x000f6;nkem&#x000f6;ller V, Konarev PV, Cassetta A, Brancaccio A, Sciandra F. A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:266–80.</span> [<a href="/pubmed/29134705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29134705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.stevens.2013.354">Stevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, Feng L, Haliloglu G, Orhan D, Dobyns WB, Enns GM, Manning M, Krause A, Salih MA, Walsh CA, Hurles M, Campbell KP, Manzini MC, Stemple D, Lin YY, Muntoni F, et al.  Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of alpha-dystroglycan. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:354–65.</span> [<a href="/pmc/articles/PMC3591840/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3591840</span></a>] [<a href="/pubmed/23453667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23453667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.takaso.2010.493">Takaso M, Nakazawa T, Imura T, Okada T, Ueno M, Saito W, Takahashi K, Yamazaki M, Ohtori S. Surgical correction of spinal deformity in patients with congenital muscular dystrophy. <span><span class="ref-journal">J Orthop Sci. </span>2010;<span class="ref-vol">15</span>:493–501.</span> [<a href="/pubmed/20721717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20721717</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.taniguchi.2003.527">Taniguchi K, Kobayashi K, Saito K, Yamanouchi H, Ohnuma A, Hayashi YK, Manya H, Jin DK, Lee M, Parano E, Falsaperla R, Pavone P, Van Coster R, Talim B, Steinbrecher A, Straub V, Nishino I, Topaloglu H, Voit T, Endo T, Toda T. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:527–34.</span> [<a href="/pubmed/12588800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12588800</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.taniguchi.2006.489">Taniguchi M, Kurahashi H, Noguchi S, Sese J, Okinaga T, Tsukahara T, Guicheney P, Ozono K, Nishino I, Morishita S, Toda T. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha-2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease? <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2006;<span class="ref-vol">342</span>:489–502.</span> [<a href="/pubmed/16487936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16487936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.taniguchiikeda.2011.127">Taniguchi-Ikeda M, Kobayashi K, Kanagawa M, Yu C, Mori K, Oda T, Kuga A, Kurahashi H, Akman HO, DiMauro S, Kaji R, Yokota T, Takeda S, Toda T. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">478</span>:127–31.</span> [<a href="/pmc/articles/PMC3412178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3412178</span></a>] [<a href="/pubmed/21979053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21979053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.taniguchiikeda.2016.115">Taniguchi-Ikeda M, Morioka I, Iijima K, Toda T. Mechanistic aspects of the formation of &#x003b1;-dystroglycan and therapeutic research for the treatment of &#x003b1;-dystroglycanopathy: a review. <span><span class="ref-journal">Mol Aspects Med. </span>2016;<span class="ref-vol">51</span>:115–24.</span> [<a href="/pubmed/27421908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27421908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.tsutsumi.1989.413">Tsutsumi A, Uchida Y, Osawa M, Fukuyama Y. Ocular findings in Fukuyama type congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>1989;<span class="ref-vol">11</span>:413–9.</span> [<a href="/pubmed/2618965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2618965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.vannoy.2017.31">Vannoy CH, Xiao W, Lu P, Xiao X, Lu QL. Efficacy of gene therapy is dependent on disease progression in dystrophic mice with mutations in the FKRP gene. <span><span class="ref-journal">Mol Ther Methods Clin Dev. </span>2017;<span class="ref-vol">5</span>:31–42.</span> [<a href="/pmc/articles/PMC5415313/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5415313</span></a>] [<a href="/pubmed/28480302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28480302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.voglmeir.2011.447">Voglmeir J, Kaloo S, Laurent N, Meloni MM, Bohlmann L, Wilson IB, Flitsch SL. Biochemical correlation of activity of the &#x003b1;-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease. <span><span class="ref-journal">Biochem J. </span>2011;<span class="ref-vol">436</span>:447–55.</span> [<a href="/pmc/articles/PMC3133881/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3133881</span></a>] [<a href="/pubmed/21361872" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21361872</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.vuillaumierbarrot.2009.182">Vuillaumier-Barrot S, Quijano-Roy S, Bouchet-Seraphin C, Maugenre S, Peudenier S, Van den Bergh P, Marcorelles P, Avila-Smirno D, Chelbi M, Romero NB, Carlier RY, Estournet B, Guicheney P, Seta N. Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype. <span><span class="ref-journal">Neuromusc Disord. </span>2009;<span class="ref-vol">19</span>:182–8.</span> [<a href="/pubmed/19179078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19179078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.wang.2010.1559">Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, Aloysius A, Bash RO, B&#x000e9;roud C, Bertini E, Bushby K, Cohn RD, Connolly AM, Deconinck N, Desguerre I, Eagle M, Estournet-Mathiaud B, Ferreiro A, Fujak A, Goemans N, Iannaccone ST, Jouinot P, Main M, Melacini P, Mueller-Felber W, Muntoni F, Nelson LL, Rahbek J, Quijano-Roy S, Sewry C, Storhaug K, Simonds A, Tseng B, Vajsar J, Vianello A, Zeller R, et al.  Consensus statement on standard of care for congenital muscular dystrophies. <span><span class="ref-journal">J Child Neurol. </span>2010;<span class="ref-vol">25</span>:1559–81.</span> [<a href="/pmc/articles/PMC5207780/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5207780</span></a>] [<a href="/pubmed/21078917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21078917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.watanabe.2005.344">Watanabe M, Kobayashi K, Jin F, Park KS, Yamada T, Tokunaga K, Toda T. Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and Northeast Asian populations. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">138</span>:344–8.</span> [<a href="/pubmed/16222679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16222679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.xu.2013.1832">Xu L, Lu PJ, Wang CH, Keramaris E, Qiao C, Xiao B, Blake DJ, Xiao X, Lu QL. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of &#x003b1;-dystroglycan and improves muscle functions. <span><span class="ref-journal">Mol Ther. </span>2013;<span class="ref-vol">21</span>:1832–40.</span> [<a href="/pmc/articles/PMC3808132/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3808132</span></a>] [<a href="/pubmed/23817215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23817215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.yamamoto.2017.861">Yamamoto T, Taniguchi-Ikeda M, Awano H, Matsumoto M, Lee T, Harada R, Imanishi T, Hayashi N, Sakai Y, Morioka I, Takeshima Y, Iijima K, Saegusa J, Toda T. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2017;<span class="ref-vol">39</span>:861–8.</span> [<a href="/pubmed/28578814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28578814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.yang.2015.880">Yang H, Kobayashi K, Wang S, Jiao H, Xiao J, Toda T, Wu X, Xiong H. Founder mutation causes classical Fukuyama congenital muscular dystrophy (FCMD) in Chinese patients. <span><span class="ref-journal">Brain Dev. </span>2015;<span class="ref-vol">37</span>:880–6.</span> [<a href="/pubmed/25814170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25814170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.yis.2011.20">Yis U, Uyanik G, Heck PB, Smitka M, Nobel H, Ebinger F, Dirik E, Feng L, Kurul SH, Brocke K, Unalp A, &#x000d6;zer E, Cakmakci H, Sewry C, Cirak S, Muntoni F, Hehr U, Morris-Rosendahl DJ. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype. <span><span class="ref-journal">Neuromuscul Disord. </span>2011;<span class="ref-vol">21</span>:20–30.</span> [<a href="/pubmed/20961758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20961758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.yoshioka.2009.419">Yoshioka M. Phenotypic spectrum of fukutinopathy: most severe phenotype of fukutinopathy. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:419–22.</span> [<a href="/pubmed/18834683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18834683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.yoshioka.2008.59">Yoshioka M, Higuchi Y, Fujii T, Aiba H, Toda T. Seizure-genotype relationship in Fukuyama-type congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2008;<span class="ref-vol">30</span>:59–67.</span> [<a href="/pubmed/17597323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17597323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fcmd.REF.yoshioka.2017.869">Yoshioka M, Kobayashi K, Toda T. Novel FKRP mutations in a Japanese MDC1C sibship clinically diagnosed with Fukuyama congenital muscular dystrophy. <span><span class="ref-journal">Brain Dev. </span>2017;<span class="ref-vol">39</span>:869–72.</span> [<a href="/pubmed/28629604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28629604</span></a>]</div></li></ul></div></div><div id="fcmd.Chapter_Notes"><h2 id="_fcmd_Chapter_Notes_">Chapter Notes</h2><div id="fcmd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>3 July 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 May 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 January 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>8 October 2004 (ks) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1206</span><span class="label">PMID: <a href="/pubmed/20301385" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301385</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fryns/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fum/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1206&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1206/?report=reader">PubReader</a></li><li><a href="/books/NBK1206/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1206" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1206" style="display:none" title="Cite this Page"><div class="bk_tt">Saito K. Fukuyama Congenital Muscular Dystrophy. 2006 Jan 26 [Updated 2019 Jul 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1206/pdf/Bookshelf_NBK1206.pdf">PDF version of this page</a> (261K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#fcmd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#fcmd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#fcmd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#fcmd.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#fcmd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#fcmd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#fcmd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#fcmd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#fcmd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#fcmd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#fcmd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2218[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FKTN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1470704" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470704" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470704" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1470704" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22675738" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">LAMA2</i>-Related Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">LAMA2</i>-Related Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quijano-Roy S, Sparks SE, Rutkowski A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301565" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malicdan MCV, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301490" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calpainopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calpainopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Angelini C, Fanin M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301609" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bonne G, Leturcq F, Ben Yaou R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301385" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301385" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410f6dd21425a259af5e0">Fukuyama Congenital Muscular Dystrophy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Fukuyama Congenital Muscular Dystrophy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:46:31-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88A54EE04058810000000004BC01A8&amp;ncbi_session=CE88A54EE0410F61_1212SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1206%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1206&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1206/&amp;ncbi_pagename=Fukuyama Congenital Muscular Dystrophy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88A54EE0410F61_1212SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>